Diamines & Chemicals has announced receiving regulatory approval from the Gujarat Pollution Control Board (GPCB) for a product mix amendment at its existing manufacturing facility. The company disclosed this development under Regulation 30 of SEBI regulations on January 22, 2026.

Regulatory Approval Details

The company received the Product Mix Consolidated Consent & Authorization (CC&A) Amendment on January 21, 2026. This approval enables Diamines and Chemicals Limited to set up industrial plant activities in its existing manufacturing unit for the production of new items and products as specified in the detailed order AWH-151692.

Business Impact and Significance

According to the company's disclosure, the CC&A serves as the final permission to manufacture new products and is expected to contribute to an increase in total production capacity. This regulatory clearance allows the company to expand its product portfolio within its existing manufacturing infrastructure.

Compliance and Disclosure

The announcement was made in compliance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, which requires disclosure for granting, withdrawal, surrender, cancellation, or suspension of key licenses or regulatory approvals. Company Secretary Hemaxi Pawar signed the disclosure document on January 22, 2026.

Manufacturing Unit Enhancement

The consent specifically covers the setting up of industrial plant activities in the company's existing manufacturing unit. This approach allows Diamines and Chemicals Limited to leverage its current infrastructure while expanding its manufacturing capabilities for new product lines as detailed in the GPCB order.

Diamines & Chemicals Limited (DACL) has reported a net loss of ₹370.04 lakhs for the second quarter, according to the company's latest financial results. This marks a significant improvement from the ₹623.47 lakh loss reported in the same quarter of the previous year.

Revenue Decline

The specialty chemicals manufacturer saw its revenue from operations decrease to ₹930.23 lakhs in Q2, compared to ₹2,153.18 lakhs in the same quarter of the previous year. This represents a substantial year-over-year decline of about 56.8%.

Half-Year Performance

For the first half of the fiscal year, DACL reported:

The company has managed to narrow its losses despite the significant drop in revenue.

Segment Performance

DACL operates in two segments:

1. Specialty Chemicals
2. Trading in Fruits and Vegetables

However, the company did not report any revenue from the Trading in Fruits and Vegetables segment for the current quarter.

Financial Metrics

• Basic Earnings Per Share (EPS) for Q2 stood at negative ₹3.78.
• The company's total expenses for Q2 were ₹1,402.69 lakhs, compared to ₹1,614.27 lakhs in the same quarter of the previous year.

Corporate Governance

The Board of Directors met on November 5 to approve the unaudited financial results. In compliance with SEBI regulations, the trading window for directors and designated employees was closed from October 1 and will reopen on November 8.

Outlook

While DACL has shown improvement in reducing its net loss compared to the previous year, the significant decline in revenue presents challenges. The company's performance in the coming quarters will be crucial in determining its ability to return to profitability and growth.